Clinical Assessment and Risk Stratification in Differentiated Thyroid Cancer

• Autores: Fernanda Vaisman, R. Michael Tuttle
• Localización: Endocrinology and metabolism clinics of North America, ISSN 0889-8529, Vol. 48, Nº. 1, 2019, págs. 99-108
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Thyroid cancer management is rapidly evolving to a personalized management approach. Risk stratification systems are designed to assist in personalized management. Differentiating patients who may benefit from aggressive therapy and intense follow-up as opposed to those who can be successfully treated with minimalized initial management options and follow-up is crucial to the development of the right treatment plan for the right patient in order to optimize initial therapy and follow-up testing. This article aims to describe and discuss the risk stratification systems currently recommended for differentiated thyroid cancer.